✦ LIBER ✦

Effect of Age on Breast Cancer Outcomes in Women With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From a Herceptin Adjuvant Trial

✍ Scribed by Partridge, A. H.; Gelber, S.; Piccart-Gebhart, M. J.; Focant, F.; Scullion, M.; Holmes, E.; Winer, E. P.; Gelber, R. D.

Book ID: 121425992
Publisher: American Society of Clinical Oncology
Year: 2013
Tongue: English
Weight: 157 KB
Volume: 31
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2012.44.1956

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab Retreatment after Relapse on

Trastuzumab Retreatment after Relapse on Adjuvant Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Final Results of the Retreatment after Herceptin Adjuvant Trial

✍ Láng, I.; Bell, R.; Feng, F.Y.; Lopez, R.I.; Jassem, J.; Semiglazov, V.; Al-Saka 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 448 KB

Adjuvant trastuzumab reduces locoregiona

Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer

✍ Ana P. Kiess; Heather L. McArthur; Kathleen Mahoney; Sujata Patil; Patrick G. Mo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

Use of adjuvant trastuzumab in women wit

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network

✍ Rachel A. Freedman; Melissa E. Hughes; Rebecca A. Ottesen; Jane C. Weeks; Yulei 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Erratum to: Trastuzumab: a review of its

Erratum to: Trastuzumab: a review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer

✍ KP Garnock-Jones, GM Keating, LJ Scott 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 49 KB

Phase IIa Trial of Trastuzumab Emtansine

Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive, Locally Advanced, or Metastatic Breast Cancer

✍ Miller, K. D.; Dieras, V.; Harbeck, N.; Andre, F.; Mahtani, R. L.; Gianni, L.; A 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 148 KB

The SystHERs registry: an observational

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer

✍ Tripathy, Debu; Rugo, Hope S; Kaufman, Peter A; Swain, Sandra; O’Shaughnessy, Jo 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 345 KB